BioCapital Investments L.P.
BioCapital Investments L.P. is a Montréal-based private investment partnership founded in 1996 that provides capital and strategic advisory services to bio and pharma startups seeking growth financing and industry expertise.
- Company typePrivate
- Founded1996
- HeadquartersMontréal, Canada
- Headcount1–10
- GTM typeB2B
- OfferingServices
BioCapital Investments L.P. firmographics
Firmographics- Name
- BioCapital Investments L.P.
- Website
- https://biocapital.com
- Company type
- Private
- Founded year
- 1996
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- BioCapital Investments L.P. is a Montréal-based private investment partnership founded in 1996 that provides capital and strategic advisory services to bio and pharma startups seeking growth financing and industry expertise.
- Ownership category
- akta.pro rank
BioCapital Investments L.P. industry classification
Industry- Product category
- Venture Capital
- NAICS
- Portfolio Management and Investment Advice (52394), Other Financial Investment Activities (5239)
- SIC
- Investment Advice (6282), Investors, Nec (6799)
- akta.pro primary industry
- Sector-Focused Venture Capital (Vertical Specialists) (FSANAAAD)
- akta.pro secondary industry
- Healthcare & Life Sciences Growth Equity (FSANACAB)
Keywords
Where BioCapital Investments L.P. is headquartered
LocationHeadquarters
- HQ city
- Montréal
- HQ country
- Canada
- HQ region
- North America
Markets served
BioCapital Investments L.P. business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Others
BioCapital Investments L.P. product offering
Product offeringCore offering
BioCapital Investments L.P. is a privately held venture capital and investment firm that provides growth capital and strategic advisory services to early-stage and emerging companies in the bio and pharmaceutical sectors. Operating from Montréal, Canada since 1996, the firm focuses its investment activity on bio and pharma startups seeking both funding and operational guidance.
Differentiator
Problem solved
Functional benefit
Products and services
- Growth Capital Investment
- Strategic Advisory Services
Companies that use BioCapital Investments L.P.
Customer profileSegments1 record
Ideal customer profiles1 record
BioCapital Investments L.P. technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
BioCapital Investments L.P. competitors and assessment
Company assessmentDirect peers
- Versant Ventures: Versant Ventures is a healthcare-focused venture capital firm that invests across bio/pharma, medical devices, and healthcare services. It is a direct peer given its sector specialization and support for early-stage bio/pharma companies.
- Frazier Healthcare Partners: Frazier Healthcare Partners is a healthcare-focused venture and growth equity firm investing across biopharma and healthcare services. It is a direct peer given its bio/pharma investing focus and combined capital-plus-strategic-support model.
- Forbion: Forbion is a leading European life sciences venture capital firm focused on investing in bio/pharma companies. It is a direct peer due to its dedicated biotech mandate and active portfolio support model, similar in value proposition to BioCapital's stated capital-plus-advisory offering.
- Polaris Partners: Polaris Partners is a multi-stage venture firm with a significant life sciences practice investing in bio/pharma startups. It is a direct peer given its active bio/pharma franchise and similar capital-plus-advisory value proposition to portfolio companies.
- Atlas Venture: Atlas Venture is a Boston-based early-stage venture capital firm that focuses exclusively on building biotech startups. It is a direct peer given its pure-play bio/pharma thesis and active company-building model.
- ARCH Venture Partners: ARCH Venture Partners is a leading early-stage venture firm focused on building biotech, pharma, and technology companies from scientific breakthroughs. It is a direct peer given its bio/pharma focus and long-term founder partnership model.
- Domain Associates: Domain Associates was a healthcare-dedicated venture capital firm focused on life sciences investments across therapeutics, medical devices, and diagnostics. It is a direct peer given its bio/pharma focus and similar specialized mandate.
- OrbiMed: OrbiMed is one of the largest healthcare-dedicated investment firms globally, investing across biopharma, medical devices, diagnostics, and digital health. It is a direct peer to BioCapital given its specialized focus on bio/pharma startups, though at vastly greater scale and AUM.
Regional players
- Teralys Capital: Teralys Capital is a Canadian private investment fund manager specializing in life sciences, cleantech, and ICT. It is a regional peer given its Canadian base and active life sciences investing mandate, similar to BioCapital's Montreal footprint and bio/pharma focus.
- Lumira Ventures: Lumira Ventures (formerly known as CTI Life Sciences Fund) is a Canadian venture capital firm focused exclusively on life sciences, particularly bio/pharma. It is a regional peer given its Canadian domicile, bio/pharma-only mandate, and similar advisory-plus-capital model.
Market position
Customer concentration
BioCapital Investments L.P. social profiles
Digital presenceBioCapital Investments L.P. financial estimates
Financial estimateRevenue estimate
Valuation estimate
BioCapital Investments L.P. leadership team
Management profileNumber of profiles
BioCapital Investments L.P. funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
BioCapital Investments L.P. M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about BioCapital Investments L.P.
What does BioCapital Investments L.P. do?
BioCapital Investments L.P. is a privately held venture capital and investment firm that provides growth capital and strategic advisory services to early-stage and emerging companies in the bio and pharmaceutical sectors. Operating from Montréal, Canada since 1996, the firm focuses its investment activity on bio and pharma startups seeking both funding and operational guidance.
When was BioCapital Investments L.P. founded?
BioCapital Investments L.P. was founded in 1996. It employs 1 to 10 people.
Where is BioCapital Investments L.P. based?
BioCapital Investments L.P. is headquartered in Montréal, Canada, in the North America region.
Who are BioCapital Investments L.P.'s main competitors?
Direct peers on record are Versant Ventures, Frazier Healthcare Partners, Forbion, Polaris Partners, Atlas Venture, ARCH Venture Partners, Domain Associates and OrbiMed. Regional players are Teralys Capital and Lumira Ventures.
Does BioCapital Investments L.P. have an API?
No public API is recorded for BioCapital Investments L.P..
What industry is BioCapital Investments L.P. in?
BioCapital Investments L.P.'s product category is Venture Capital. Its primary akta.pro industry code is FSANAAAD, Sector-Focused Venture Capital (Vertical Specialists), with a secondary code of FSANACAB, Healthcare & Life Sciences Growth Equity. Its NAICS code is 52394 and its SIC code is 6282.